RETRACTED: Notoginsenoside R1 protects human renal proximal tubular epithelial cells from lipopolysaccharide-stimulated inflammatory damage by up-regulation of miR-26a-Reference-Cited by-同舟云学术

RETRACTED: Notoginsenoside R1 protects human renal proximal tubular epithelial cells from lipopolysaccharide-stimulated inflammatory damage by up-regulation of miR-26a

Published:2019-08 Issue: Volume:308 Page:364-371
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Liu Jinrong,Hou Cun,Chen Xiaoyuan,Wu Lin,Wang Xinyue

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference39 articles.

1. Lipopolysaccharide induces chronic kidney injury and fibrosis through activation of mTOR signaling in macrophages;Chen;Am. J. Nephrol.,2015

2. beta-d-glucan from Antrodia Camphorata ameliorates LPS-induced inflammation and ROS production in human hepatocytes;Chen;Int. J. Biol. Macromol.,2017

3. Renal anatomy and overview of nephron function;Chmielewski;Nephrol. Nurs. J.,2003

4. Up-regulation of miR-26a promotes neurite outgrowth and ameliorates apoptosis by inhibiting PTEN in bupivacaine injured mouse dorsal root ganglia;Cui;Cell Biol. Int.,2015

5. Chronic kidney disease;Delles;Clin. Sci. (Lond.),2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nrf2/HO-1 as a therapeutic target in renal fibrosis;Life Sciences;2023-12

2. Retraction notice to “Notoginsenoside R1 protects human renal proximal tubular epithelial cells from lipopolysaccharide-stimulated inflammatory damage by up-regulation of miR-26a” [Chem. Biol. Interact. 308 (2019) 364–371];Chemico-Biological Interactions;2022-04

3. Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway;Open Medicine;2022-01-01

4. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease;Frontiers in Pharmacology;2021-03-29

5. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm;Frontiers in Pharmacology;2020-12-11